Constructive Bio Wins Life Science Scale-Up Award

Our Chief of Staff, Dr Helena Francis and CEO, Dr Ola Wlodek, received the Life Science Scale-Up accolade from Sheena Desai of Aviva Investors, representing Chesterford Research Park.

Constructive Bio wins ‘Life Science Scale-Up Award’ at the 35th Anniversary Business Weekly Awards, held at Queen’s College, Cambridge on Monday, 15th September 2025.

Sheena Desai of Aviva Investors, representing Chesterford Research Park, introduced the Life Science Scale-Up Award. There was immense competition with a host of scaling companies in the mix, both from the prolific Cambridge cluster and surrounding areas such as the Stevenage Bioscience Catalyst.

Sheena explained that Constructive Bio was a genuine pioneer in genome writing and genetic code reprogramming. The company explores uncharted chemical space to build programmable molecules, well beyond those found in nature, she said, with applications across multiple industries.

We are very proud to receive further recognition for our pioneering biotechnology. Thank you to the organisers for a fantastic event, and the judging panel for championing us.

About Constructive Bio

At Constructive Bio we rewrite the genome to build the biomolecules of the future. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.

Through exclusive access to breakthrough science from the MRC Laboratory of Molecular Biology, based on the research carried out by our founder Professor Jason Chin, Constructive Bio alone has the ability to rewrite entire genomes and incorporate multiple non-canonical amino acids in a single molecule.

Constructive Bio is realising the full scientific and commercial potential of its technologies through its proprietary platforms. These include:

 Full genome synthesis: We assemble DNA into genome-scale pieces, stitching and replacing megabases of DNA inside living cells. Through this process, we create entirely new genomes from scratch, writing the genetic blueprint of cells with unprecedented flexibility and precision.

 Engineered protein translation: Constructive Bio synthesises proteins with expanded functions by incorporating non-canonical amino acids (ncAAs). Through reprogramming the genetic code of cells and expanding their repertoire of chemical building blocks, our technology creates biofactories for the discovery and manufacturing of novel biopolymers. These molecules have unique properties and diverse applications across science and industry, including pharmaceuticals, agriculture and biomaterials.